Genomic Profiling of Thyroid Nodules: Current Role for ThyroSeq Next-Generation Sequencing on Clinical Decision-Making
Molecular Imaging and Radionuclide Therapy · 2017
DOI: 10.4274/2017.26.suppl.04 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Imaging and Radionuclide Therapy, 2017. Verfasst von Atil Y Kargi und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of Miami Hospital, Clinic of Diabetes and Metabolism, Division of Endocrinology, Florida, USA, Phone: 305-243-3636, E-mail: akargi@med.mia…. Die Arbeit wurde bisher 16-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- University of Miami Hospital, Clinic of Diabetes and Metabolism, Division of Endocrinology, Florida, USA, Phone: 305-243-3636, E-mail: akargi@med.miami.edu.
Zitieren
APA
Kargi, A. Y., Bustamante, M. P., & Gulec, S. (2017). Genomic Profiling of Thyroid Nodules: Current Role for ThyroSeq Next-Generation Sequencing on Clinical Decision-Making. Molecular Imaging and Radionuclide Therapy. https://doi.org/10.4274/2017.26.suppl.04
Vancouver
Kargi AY, Bustamante MP, Gulec S. Genomic Profiling of Thyroid Nodules: Current Role for ThyroSeq Next-Generation Sequencing on Clinical Decision-Making. Molecular Imaging and Radionuclide Therapy. 2017. doi:10.4274/2017.26.suppl.04
BibTeX
@article{Kargi2017,
author = {Kargi, Atil Y and Bustamante, Marcela Perez and Gulec, Seza},
title = {Genomic Profiling of Thyroid Nodules: Current Role for ThyroSeq Next-Generation Sequencing on Clinical Decision-Making},
journal = {Molecular Imaging and Radionuclide Therapy},
year = {2017},
doi = {10.4274/2017.26.suppl.04}
}
EUVIMED